共 50 条
- [23] Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (07): : 900 - 909
- [24] Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database [J]. Clinical and Translational Oncology, 2019, 21 : 900 - 909
- [25] Patient-Reported Quality of Life Outcomes in Intermediate-Risk Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S25 - S25
- [26] Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation Study [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1066 - 1073
- [28] A Dosimetric and Clinical Evaluation of Monotherapy With Hypofractionated Stereotactic Body Radiation Therapy in the Treatment of Intermediate-Risk Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S827 - S827
- [29] A Phase I Dose Escalation Study of Stereotactic Body Radiation Therapy (SBRT) for Low-and Intermediate-risk Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S80 - S80